Results 161 to 170 of about 8,788 (204)

Nirmatrelvir+ritonavir/tacrolimus

Reactions Weekly, 2023
  +9 more sources

Nirmatrelvir+ritonavir

Reactions Weekly, 2022
openaire   +2 more sources

Nirmatrelvir+ritonavir/tacrolimus

Reactions Weekly, 2022
  +4 more sources

Nirmatrelvir+ritonavir

Reactions Weekly
  +5 more sources

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

New England Journal of Medicine, 2022
Weihang Bao, Bharat Damle
exaly  

Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study

Lancet, The, 2022
Chi Ho Au, Kristy Tsz Kwan Lau
exaly  

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

New England Journal of Medicine, 2022
Ronen Arbel, Noa Dagan, Ariel Hammerman
exaly  

Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

Nature, 2022
Sho Iketani, Hiroshi Mohri, Bruce Culbertson   +2 more
exaly  

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19

New England Journal of Medicine, 2023
Zhujun Cao, Gui Honglian, Yuan Gao
exaly  

Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir

Nature, 2023
Yinkai Duan, Sho Iketani, Mengmeng Lin
exaly